Molecular Tongs Containing Amino Acid Mimetic Fragments: New Inhibitors of Wild-Type and Mutated HIV-1 Protease Dimerization
Citations Over TimeTop 14% of 2006 papers
Abstract
We have designed, synthesized, and evaluated the inhibitory activity and metabolic stability of new peptidomimetic molecular tongs based on a naphthalene scaffold for inhibiting HIV-1 protease dimerization. Peptidomimetic motifs were inserted into one peptidic strand to make it resistant to proteolysis. The peptidic character of the molecular tongs can be decreased without changing the way they inhibit dimerization. Mutated HIV-1 proteases are also vulnerable to dimerization inhibitors, and the multimutated protease ANAM-11 is twice as sensitive to the inhibitor compared to wild-type protease. Thus, the metabolic stability of antidimeric molecular tongs can be increased without compromising their ability to inhibit wild-type and mutated HIV-1 proteases in vitro.
Related Papers
- → HIV-1 Protease Inhibitors: A Comparative QSAR Analysis(2003)39 cited
- → Structure Based Design of Inhibitors of Aspartic Protease of HIV-1(2005)9 cited
- → Acute thrombocytopenia secondary to the administration of the peptidomimetic HIV protease inhibitor MK-639 (L735524)(1996)21 cited
- → X-Ray Diffraction data from HIV-1 protease with a peptidomimetic inhibitor ("WT-SE"), source of 1FQX structure(2019)
- → Developments in peptide synthesis and peptidomimetic chemistry: HIV protease analogs and substrate-based inhibitors(2006)